Skip to main content
Long-term cotrimoxazole may benefit kids with HIV

Children with HIV given cotrimoxazole prophylaxis along with antiretroviral therapy for at least 96 weeks and who continued receiving cotrimoxazole for another 96 weeks had reduced systemic inflammation compared with those who didn't receive the additional 96 weeks, researchers reported in Science Translational Medicine. AIDS-related adverse outcomes were more likely 48 weeks after discontinuing cotrimoxazole.

Full Story: